TNSN00211A1 - Derives d'hygromycine a nouveaux, compositions les contenant et leur utilisation - Google Patents

Derives d'hygromycine a nouveaux, compositions les contenant et leur utilisation

Info

Publication number
TNSN00211A1
TNSN00211A1 TNTNSN00211A TNSN00211A TNSN00211A1 TN SN00211 A1 TNSN00211 A1 TN SN00211A1 TN TNSN00211 A TNTNSN00211 A TN TNSN00211A TN SN00211 A TNSN00211 A TN SN00211A TN SN00211 A1 TNSN00211 A1 TN SN00211A1
Authority
TN
Tunisia
Prior art keywords
compositions containing
novel
derivatives
hygromycin derivatives
novel hygromycin
Prior art date
Application number
TNTNSN00211A
Other languages
English (en)
Inventor
Merril Hayward Matthew
Elizabeth Brighty Katherine
Kaneko Takushi
Gerald Linde Ii Robert
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN00211A1 publication Critical patent/TNSN00211A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'INVENTION CONCERNE DES COMPOSES DE FORMULE I : DANS LAQUELLE V, X, Y, Z1, Z2, W1 ET W2 REPRESENTENT DIVERS RADICAUX. ELLE CONCERNE EGALEMENT DES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT. APPLICATION : TRAITEMENT D'INFECTIONS BACTERIENNES ET D'INFECTIONS PAR DES PROTOZOAIRES CHEZ DES MAMMIFERES PAR ADMINISTRATION DE CES COMPOSES ET COMPOSITIONS.
TNTNSN00211A 1999-10-29 2000-10-27 Derives d'hygromycine a nouveaux, compositions les contenant et leur utilisation TNSN00211A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16258199P 1999-10-29 1999-10-29

Publications (1)

Publication Number Publication Date
TNSN00211A1 true TNSN00211A1 (fr) 2005-11-10

Family

ID=22586256

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN00211A TNSN00211A1 (fr) 1999-10-29 2000-10-27 Derives d'hygromycine a nouveaux, compositions les contenant et leur utilisation

Country Status (32)

Country Link
US (1) US6562792B1 (fr)
EP (1) EP1224197A1 (fr)
JP (1) JP2003512473A (fr)
KR (1) KR20020063885A (fr)
CN (1) CN1382150A (fr)
AP (1) AP2002002494A0 (fr)
AR (1) AR023282A1 (fr)
AU (1) AU7549400A (fr)
BG (1) BG106727A (fr)
BR (1) BR0015153A (fr)
CA (1) CA2389191A1 (fr)
CO (1) CO5261498A1 (fr)
CZ (1) CZ20021355A3 (fr)
EA (1) EA200200292A1 (fr)
EE (1) EE200200228A (fr)
GT (1) GT200000185A (fr)
HK (1) HK1049672A1 (fr)
HU (1) HUP0203525A3 (fr)
IL (1) IL148577A0 (fr)
IS (1) IS6311A (fr)
MA (1) MA26838A1 (fr)
MX (1) MXPA02004360A (fr)
NO (1) NO20021850L (fr)
OA (1) OA12081A (fr)
PA (1) PA8505801A1 (fr)
PE (1) PE20010763A1 (fr)
PL (1) PL357083A1 (fr)
SK (1) SK5472002A3 (fr)
SV (1) SV2002000211A (fr)
TN (1) TNSN00211A1 (fr)
TR (1) TR200201145T2 (fr)
WO (1) WO2001030795A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152984A0 (en) 2000-06-02 2003-06-24 Pfizer Prod Inc Hygromycin a derivatives for the treatment of bacterial and protozoal infections
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
US7923439B2 (en) * 2008-10-15 2011-04-12 Tyco Healthcare Group Lp Hydroxamate compositions
US20210275559A1 (en) * 2018-08-20 2021-09-09 Kim Lewis Hygromycin a compounds and methods of treating spirochete diseases
CR20220316A (es) 2019-12-06 2022-10-07 Vertex Pharma Tetrahidrofuranos sustituidos como moduladores de canales de sodio
CN117794920A (zh) 2021-06-04 2024-03-29 沃泰克斯药物股份有限公司 N-(羟烷基(杂)芳基)四氢呋喃甲酰胺作为钠通道调节剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL348063A1 (en) * 1998-12-02 2002-05-06 Pfizer Prod Inc Hygromycin a derivatives as antibacterial agents

Also Published As

Publication number Publication date
JP2003512473A (ja) 2003-04-02
PL357083A1 (en) 2004-07-12
CZ20021355A3 (cs) 2002-11-13
GT200000185A (es) 2002-04-18
HK1049672A1 (zh) 2003-05-23
KR20020063885A (ko) 2002-08-05
NO20021850D0 (no) 2002-04-19
SV2002000211A (es) 2002-07-16
IL148577A0 (en) 2002-09-12
CN1382150A (zh) 2002-11-27
HUP0203525A2 (hu) 2003-02-28
AR023282A1 (es) 2002-09-04
BR0015153A (pt) 2002-07-16
AP2002002494A0 (en) 2002-06-30
CO5261498A1 (es) 2003-03-31
PA8505801A1 (es) 2002-08-26
BG106727A (bg) 2003-01-31
TR200201145T2 (tr) 2002-09-23
SK5472002A3 (en) 2003-02-04
PE20010763A1 (es) 2001-07-25
CA2389191A1 (fr) 2001-05-03
US6562792B1 (en) 2003-05-13
WO2001030795A1 (fr) 2001-05-03
IS6311A (is) 2002-03-19
AU7549400A (en) 2001-05-08
OA12081A (en) 2006-05-04
NO20021850L (no) 2002-04-19
EA200200292A1 (ru) 2002-10-31
EP1224197A1 (fr) 2002-07-24
MXPA02004360A (es) 2002-11-07
HUP0203525A3 (en) 2003-08-28
MA26838A1 (fr) 2004-12-20
EE200200228A (et) 2003-06-16

Similar Documents

Publication Publication Date Title
TNSN98194A1 (fr) Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99236A1 (fr) Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99142A1 (fr) Derives de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procede pour leur preparation.
TNSN99252A1 (fr) Composes nouveaux modulateurs de chimiokine ccr5 et compositions pharmaceutiques les contenant.
TNSN98082A1 (fr) DERIVES SUBSTITUES EN C - 4 DE 9 - DESOXO - 9a - aza - 9a HOMOERYTHROMYCINE A.
TNSN00104A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98238A1 (fr) Macrolides nouveaux
TNSN01091A1 (fr) Derives bicycliques nouveaux, compositions les contenant et leur utilisation pour le traitement d'une croissance cellulaire anormale
TNSN00228A1 (fr) Derives de benzimidazole nouveaux, et compositions les contenant
TNSN99106A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99169A1 (fr) Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98045A1 (fr) Derives de nicotinamide nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99253A1 (fr) Composes chimiques nouveaux modulateurs de ccr5, et compositions pharmaceutiques les contenant.
TNSN00092A1 (fr) Composes nouveaux antagonistes de npy, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN00191A1 (fr) Composes nouveaux, compositions les contenant et leur utilisation dans le traitement d'une ischemie
TNSN98203A1 (fr) Derives de thienopyrimidine et tienopyridine utiles comme agents anticancereux, et compositions les contenant
TNSN97198A1 (fr) Derives de 6-phenylpyridyl-2- amine et compositions pharmaceutiques les contenant
TNSN01114A1 (fr) Derives d'imidazole nouveaux et compositions les contenant
TNSN00108A1 (fr) Derives d'erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN00007A1 (fr) Macrolides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN00235A1 (fr) Derives d'heterocyclo-alkylsulfonylpyrazole nouveaux, procede pour leur preparation et compositions les contenant
TNSN99205A1 (fr) Macrolides antibiotiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99214A1 (fr) Azalides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98083A1 (fr) Derives de 6-0 methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN01100A1 (fr) Derives de glutaramide a substituant cyclopentyle, procede pour leur preparation et compositions les contenant